ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1240

Active Disease Is Associated with Dependency in Inflammatory Arthritis

Havva Ozturk Durmaz1, Alper Sari2, Berkan Armagan2, Abdulsamet Erden3, Levent Kilic2, Omer Karadag4, Sedat Kiraz2, Sule Apras Bilgen3 and Umut Kalyoncu3, 1Physical Medicine and Rehabilitation, Ahi Evran University Faculty of Medicine, Kırsehir, Turkey, 2Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 3Department of Internal Medicine, Divison of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 4Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, University of Cambridge, Cambridge, United Kingdom

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: inflammatory arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Patient Outcomes, Preferences, and Attitudes Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The independency is one of the major concerns according to patients’ perspective. For instance, independency is top ranking problem in psoriatic arthritis patients and it take part in  PsA core set domain (1).   The objectives of this study were to assess level of independency and its correlation with disease activity.

Methods: Patents with inflammatory arthritis were consecutively recruited. Age, sex, disease duration, education level, DMARD usage were recorded. Independency was assessed with visual activity scale (VAS)-independence (0-100 mm) according to patients’ perspective. VAS – independence more than 40/100 mm were defined as "dependent patient". All patients were assessed with patient global assessment (PGA), physician global assessment (PhGA), pain VAS, fatigue VAS, swollen (66 joints), and tender joint counts (68 joints). Other measures were BASDAI, BASFI, ASDAS-CRP, DAS-28, SDAI, CDAI, and HAQ. Correlation of outcome measures with independence-VAS were calculated.     

Results: Total 194 (66% female) patients (88 RA, 87 AS, 19 PsA) were enrolled to study. Mean age was 47.1±12 years-old and mean disease duration was 9.5 (7.8) years. 83 (42.8%) patients had less or equal than 5 years educational level and 104 (53.6%) patients had regular occupations. 88 (45.4%) patients were used biological DMARD. Independence-VAS score was zero in 141 (72.6%) patients and 28 patients (14.4%) had more or equal than 40 mm independence VAS score. Female patients were more frequently dependent than male patients (19.5% vs 4.5%, p=0.005). There was no difference at age, disease duration, incoming, occupation, disease type, biological DMARD usage according to dependence status. Dependent patients had worst disease activity and functional status (Table 1). Correlation of independence-VAS with other outcome measures were followed; HAQ (r=0.70), BASFI (r=0.64), BASDAI (r=0.58), PhGA (r=0.57), pain-VAS (0.57), PGA (r=0.52), CDAI (r=0.51), ASDAS-CRP (r=0.51), SDAI (r=0.48), fatigue-VAS (r=0.46),DAS-28 (r=0.42), TJC-68 joints (r=0.39), SJC-66 joints (r=0.27). 

Conclusion: Being independenct is a major goal according to patients’ perspective. Independency is closely related with functional disability and disease activity. However, when assessed with VAS score, a floor effect can be seen. For inflammatory arthritis patients, we need a well-defined instruments for the assessment of independence.

Reference:

  1. Orbai AM et al. Ann Rheum Dis. 2016;76:673-680.

Table 1: Independence level and disease activity scores

 

Independence VAS ≥40 mm n=28

Independence VAS < 40 mm n=166

P

PhGA

63 (21)

28 (20)

<0.001

PGA

69 (25)

34 (23)

<0.001

Pain-VAS

73 (29)

31 (26)

<0.001

Fatigue-VAS

73 (25)

39 (26)

<0.001

DAS-28

3.8 (1.1)

2.9 (1.3)

0.004

SDAI

19.1 (10.1)

10.9 (8.8)

0.001

CDAI

17.4 (9.6)

9.3 (8.0)

<0.001

BASDAI

6.4 (2.1)

2.5 (2.3)

<0.001

BASFI

5.5 (2.7)

1.6 (1.8)

<0.001

ASDAS

3.61 (0.88)

2.08 (1.10)

<0.001

HAQ-DI

1.0 (0.5)

0.33 (0.37)

<0.001

PhGA: Patient global assessment, PGA: physician global assessment, VAS: visual analog scale, DAS: disease activity score, SDAI: simple disease activity index, CDAI: clinical disease activity index, BASDAI: Bath ankylosing spondylitis disease activity index, BASFI: Bath ankylosing spondylitis functional index, ASDAS: Ankylosing spondylitis disease activity score, HAQ: health assessment questionnaire

 


Disclosure: H. Ozturk Durmaz, None; A. Sari, None; B. Armagan, None; A. Erden, None; L. Kilic, None; O. Karadag, None; S. Kiraz, None; S. Apras Bilgen, None; U. Kalyoncu, None.

To cite this abstract in AMA style:

Ozturk Durmaz H, Sari A, Armagan B, Erden A, Kilic L, Karadag O, Kiraz S, Apras Bilgen S, Kalyoncu U. Active Disease Is Associated with Dependency in Inflammatory Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/active-disease-is-associated-with-dependency-in-inflammatory-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/active-disease-is-associated-with-dependency-in-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology